> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Latest Federal Register Notices
- URL: https://www.fdaweb.com/latest-federal-register-notices-220/
- Published: 2019-04-21T12:00:00.000Z
- Updated: 2026-09-15T01:21:40.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5143926

[**Assessment of Quantitative Imaging Devices Guide**](https://www.fdaweb.com/assessment-of-quantitative-imaging-devices-guide/)  
*Federal Register* notice: FDA makes available a draft guidance entitled “Technical Performance Assessment of Quantitative Imaging in Premarket Device Submissions.” 04/19/2019 

[**Draft Guide on Nitinol-Containing Medical Devices**](https://www.fdaweb.com/draft-guide-on-nitinol-containing-medical-devices/)  
*Federal Register* notice: FDA announces the availability of a draft guidance entitled “Technical Considerations for Non-Clinical Assessment of Medical Devices containing Nitinol.” 04/19/2019 

[**Guide on Bispecific Antibody Development Programs**](https://www.fdaweb.com/guide-on-bispecific-antibody-development-programs-2/)  
*Federal Register* notice: FDA makes available a draft guidance entitled “Bispecific Antibody Development Programs.” 04/19/2019 

[**Comments Extended for Sunscreen Proposed Rule**](https://www.fdaweb.com/comments-extended-for-sunscreen-proposed-rule/)  
*Federal Register* notice: FDA extends the comment period for a 2/26 proposed rule on the regulation of over-the-counter sunscreen monograph products. 04/18/2019 

[**Proposed Rule on Sunscreens Corrected**](https://www.fdaweb.com/proposed-rule-on-sunscreens-corrected/)  
*Federal Register* notice: FDA corrects a 2/26 proposed rule on the regulation of over-the-counter sunscreen monograph products. 04/18/2019 

[**Info Collection Extension for Animal ANDAs**](https://www.fdaweb.com/info-collection-extension-for-animal-andas/)  
*Federal Register* notice: FDA seeks comments on an information collection extension for “Abbreviated New Animal Drug Applications — Sections 512(b)(2) and (n)(1) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360b(b)(2) and (n)(1)).” 04/18/2019 

[**Trisenox Not Withdrawn Over Safety/Efficacy: FDA**](https://www.fdaweb.com/trisenox-not-withdrawn-over-safety-efficacy-fda/)  
*Federal Register* notice: FDA determines that Cephalon’s Trisenox (arsenic trioxide) injection, 1mg/mL, was not withdrawn for safety or effectiveness reasons. 04/18/2019 

[**Info Collection Extension for Expanded Access Requests**](https://www.fdaweb.com/info-collection-extension-for-expanded-access-requests/)  
*Federal Register* notice: FDA submits to OMB an information collection extension for its “Guidance for Industry on Individual Patient Expanded Access Applications: Form FDA 3926.” 04/17/2019 

[**Info Collection Extension for CVM E-submissions**](https://www.fdaweb.com/info-collection-extension-for-cvm-e-submissions/)  
*Federal Register* notice: FDA seeks comments on an information collection extension for its “Guidance for Industry on Registering with the Center for Veterinary Medicine’s Electronic Submission System — 21 CFR 11.2” 04/16/2019